FIELD: medicine; ophthalmology.
SUBSTANCE: invention is intended for predicting visual acuity in retinitis pigmentosa (RP). Multifocal electroretinography (mfERG) of the central zone of the retina is performed according to the standard method. With a total retinal biopotential density in the fovea and parafovea of 100 or more nV/deg2, visual acuity of 0.5 or more is predicted.
EFFECT: method provides reasonable career guidance for the patient, as well as optimization of patient selection for gene therapy in PR.
1 cl, 3 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING STATE OF THE CENTRAL ZONE OF RETINA IN PATIENTS WITH SPECTRAL YELLOW INTRAOCULAR LENS | 2020 |
|
RU2746666C1 |
| METHOD FOR DETERMINING STAGES OF PIGMENT AND PIGMENTLESS PIGMENT RETINITIS | 2018 |
|
RU2707368C1 |
| METHOD FOR PREDICTING A DECREASE IN VISUAL FUNCTIONS AFTER ORGAN-PRESERVING TREATMENT FOR INITIAL CHOROIDAL MELANOMA OF EXTRAMACULAR LOCALIZATION | 2022 |
|
RU2787514C1 |
| METHOD OF DIAGNOSING ACHROMATOPSIA | 2009 |
|
RU2444977C2 |
| METHOD FOR PREDICTING OPTIC NERVE PARTIAL ATROPHY WITH STARGARDT DISEASE | 2017 |
|
RU2644693C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF SUBRETINAL FIBROSIS IN PATIENTS WITH EXUDATIVE FORM OF AGE-RELATED MACULAR DEGENERATION GIVEN ANTI-VEGF THERAPY | 2022 |
|
RU2793419C1 |
| METHOD FOR DETERMINING PIGMENTED RETINITIS DEVELOPMENT STAGES | 2004 |
|
RU2267979C1 |
| LASER TREATMENT METHOD IN CENTRAL SEROUS CHORIORETINOPATHY WITH NEUROEPITHELIAL DETACHMENT IN THE MACULAR AREA | 2020 |
|
RU2724278C1 |
| METHOD FOR DETERMINING RISK OF MACULAR DYSFUNCTION ASSOCIATED WITH MASSIVE LASER COAGULATION OF RETINA IN PERIPHERAL VITREOCHORIORETINAL DYSTROPHY | 2019 |
|
RU2732209C1 |
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF DIFFERENT STATES OF STARGARDT'S DISEASE | 2012 |
|
RU2497436C1 |
